Oxytocin + PT-141 (Spray)

Source / Derivation:

Oxytocin and PT-141 (Bremelanotide) are synthetic peptide analogs modeled after naturally occurring neuroendocrine signaling molecules involved in social bonding, arousal, and stress regulation. Both compounds are formulated for intranasal delivery to support rapid absorption and central nervous system activity.

Oxytocin + PT-141

Mechanism of Action:

Oxytocin modulates social attachment, emotional processing, and autonomic balance via oxytocin receptor activation, while PT-141 acts on melanocortin receptors (MC3R and MC4R) to stimulate central arousal pathways independent of vascular mechanisms. In combination, they support neurochemical balance and central activation of desire and emotional connectivity.

Clinical Relevance & Potential Outcomes:

Emerging data and clinical use suggest this combination may support libido, emotional well-being, intimacy response, and stress adaptation. It is also being explored for potential benefits in mood enhancement, relational bonding, and central sexual arousal pathways.

Intended Clinical Application:

This formulation may be relevant for patients experiencing reduced libido, emotional disconnection, stress-related dysregulation, or diminished arousal. It may also be considered in integrative protocols addressing neuroendocrine balance and quality-of-life optimization.

Formulation & Quality Specifications:

Delivered as a liquid prefilled pen
Purity: >98% (HPLC-validated)
Storage: 2–8 °C (refrigerated)
Documentation: Full CoA and MSDS available

Concentration:

Frequency:

Duration:

Notes:

0.05mg/ml + 2.56mg/ml, total 10ml

As needed

6 months

Combination enhances libido, promotes emotional connection, and supports central arousal pathways.

Learn More